is bpc 157 fda approved human use staff question peptides ahead of review, Kennedy a fan bpc-157 fda warning not approved
Description
doi: 10.1111/j.1365-2265.1995.tb02929.x 103 RaunKHansenBSJohansenNLThogersenHMadsenKAnkersenMet al
doi: 10.1186/s12920-022-01424-4 131 ArboledaVALeeHDorraniNZadehNWillisMMacmurdoCFet al
Douglas LM, Konopka JB
Cognitive impairment : problems with concentration, memory impairment, brain fog, and difficulties with decision-making
The clinical drug development program was halted in 2007 after the pivotal Phase IIb trial did not show statistically significant weight loss in the primary endpoint
